Histone Deacetylation Inhibition in Pulmonary Hypertension
Lan Zhao(Tianjin Fourth Central Hospital), Martin R. Wilkins(Hammersmith Hospital), Emanuele Cotroneo(Hammersmith Hospital), Min Li(Hong Kong Baptist University), Chien-Nien Chen(Hammersmith Hospital), Nabil Hajji(Imperial College London), John Wharton(Pfizer (United Kingdom)), Timothy A. McKinsey(University of Colorado Anschutz Medical Campus), Eduardo Oliver(Hammersmith Hospital), Daren Wang(Hammersmith Hospital), Kurt R. Stenmark(University of Colorado Denver)
Cited by 260
Related Papers
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k
Pediatric Pulmonary Hypertension
|Circulation|2015|1.1k
Mechanisms of disease: pulmonary arterial hypertension
|Nature Reviews Cardiology|2011|784
Basic Science of Pulmonary Arterial Hypertension for Clinicians
|Circulation|2010|488